TP53 and skin basal cell carcinoma: Regarding BCC, non-synonymous mutations in the TP53 gene have been reported in about half of sporadic cases whereas LOH has been described with a much lower frequency in BCC as compared to other tumors as colon, lung, and bladder cancers [57,58,59,60,61] (Table 1).